This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Public Health Experts Address Bristol-Myers Squibb Foundation Together On Diabetes® Grantees And Applaud Collaborations Between Clinicians And Communities To Reduce Diabetes Disparities

Public health experts from the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Public Health Service applauded grantees of the Bristol-Myers Squibb Foundation and its Together on Diabetes ® initiative for their collaborative efforts to improve health outcomes and reduce disparities for people living with type 2 diabetes by strengthening patients’ ability to manage their own care with supportive community services.

During the two-day summit at Emory University, nonprofit grantees and their partners from across the United States joined diabetes experts from the U.S. government and various academic and public health institutions to discuss how communities can build, integrate and coordinate medical, non-medical and policy efforts, and expand the base of community organizations actively bringing their know-how, reach, influence and assets to the fight against type 2 diabetes.

CDC reports that 79 million Americans are pre-diabetic and at increased risk of developing type 2 diabetes in the next 10 years. About 1.9 million new cases of diabetes are diagnosed in people age 20 and older each year. If current trends persist, as many as one in three Americans will have diabetes by 2050, CDC projects.

Nearly half of all patients who have been diagnosed with type 2 diabetes do not have their disease adequately controlled through a combination of diet, physical activity and medication. Patients with uncontrolled type 2 diabetes face increased risk of complications such as cardiovascular disease, high blood pressure and stroke; damage to the nerves, eyes and kidneys; and amputation of the fingers, toes or limbs.

“While CDC has reported declining rates of some of the most serious complications of diabetes, including kidney failure, amputation of feet and legs, hospitalizations and vision loss, we are not seeing these drops in all groups,” said Ann Albright, Ph.D., R.D., director of CDC’s Division of Diabetes Translation, who addressed the summit Tuesday. “Improving access to health care, including teaching people how to care for themselves if they have diabetes, is so important. So is strong community support for healthy lifestyles.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs